2.97
0.01 (0.17%)
Previous Close | 2.97 |
Open | 3.00 |
Volume | 521,544 |
Avg. Volume (3M) | 562,449 |
Market Cap | 107,217,296 |
Price / Sales | 2.99 |
Price / Book | 4.93 |
52 Weeks Range | |
Earnings Date | 4 Aug 2025 - 8 Aug 2025 |
Profit Margin | -15.05% |
Operating Margin (TTM) | -35.80% |
Diluted EPS (TTM) | -0.140 |
Quarterly Revenue Growth (YOY) | 161.90% |
Total Debt/Equity (MRQ) | 38.14% |
Current Ratio (MRQ) | 2.66 |
Operating Cash Flow (TTM) | -2.72 M |
Levered Free Cash Flow (TTM) | -2.37 M |
Return on Assets (TTM) | -12.72% |
Return on Equity (TTM) | -35.68% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Devices (US) | Bearish | Mixed |
Medical Devices (Global) | Bearish | Mixed | |
Stock | Myomo Inc. | - | - |
AIStockmoo Score
Analyst Consensus | -2.0 |
Insider Activity | NA |
Price Volatility | 1.5 |
Technical Moving Averages | 2.5 |
Technical Oscillators | -2.5 |
Average | -0.13 |
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, China, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals and surgery centers, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts. |
|
Sector | Healthcare |
Industry | Medical Devices |
% Held by Insiders | 5.23% |
% Held by Institutions | 60.43% |
No data within this time range.
No data within this time range.
Date | Type | Details |
---|---|---|
07 May 2025 | Announcement | Myomo Reports First Quarter 2025 Financial and Operating Results |
01 May 2025 | Announcement | Myomo to Host Investor & Analyst Day Event on June 18, 2025 |
30 Apr 2025 | Announcement | Myomo Launches the MyoPro® 2x |
30 Apr 2025 | Announcement | Myomo to Report First Quarter 2025 Financial Results on May 7 |
10 Apr 2025 | Announcement | Myomo Announces Upcoming Changes to its Board of Directors |
31 Mar 2025 | Announcement | Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |